Apple and Vertex Pharmaceuticals are top performers with growth potential despite industry challenges.

From Nasdaq: 2024-12-19 04:20:00

Apple and Vertex Pharmaceuticals, both listed on NASDAQ, have been top performers in the market over the past decade, defying industry expectations. Apple faces challenges like slowing sales and regulatory scrutiny, but its foray into artificial intelligence and strong services segment continue to drive growth potential.

Vertex Pharmaceuticals, known for cystic fibrosis drugs, is diversifying its portfolio with new treatments for rare diseases and pain management. Its revenue continues to grow, with upcoming approvals for improved cystic fibrosis therapy. Innovation remains a key driver for Vertex’s long-term success in the biotech industry.



Read more at Nasdaq: 2 Unstoppable Stocks to Buy and Hold for the Next Decade